CK-MB FIA Test
- UID
- MFG/IVD/2021/000062_cbdfd7f1a1e17f8dc58816334f797884_ccaed508d12e4fb3e686f17f84c8aefb
- Device class
- Class B
- Brand name
- hCG
- License holder
- Mylab Discovery Solutions Pvt. Ltd. Lonavla
- Approving authority
- Pune Division
- Product information
- CK-MB FIA Test is a fluorescence immunoassay for the quantitative determination of total Creatine Kinase Isoenzyme-MB (hCG) levels in the human specimen using FIA Analyzers. This test is an in vitro diagnostic use and intended for use as an aid in the screening and monitoring of myocardiac infarction (hCG). The test is intended for professional testing. More specific alternative diagnosis methods should be performed to obtain the confirmation of total CK-MB
CK-MB FIA Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000062_cbdfd7f1a1e17f8dc58816334f797884_ccaed508d12e4fb3e686f17f84c8aefb. This device is marketed under the brand name hCG. The license holder is Mylab Discovery Solutions Pvt. Ltd. Lonavla, and it is classified as Device Class Class B. The approving authority is Pune Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.